No Data
No Data
EPS HEALTH TECH: NOTICE OF BOARD MEETING
eps health tech (03860.HK) announces a profit warning: expected mid-term net profit of about 16 million Hong Kong dollars.
On November 18, Glonhui reported that eps health tech (03860.HK) announced that the group expects to record an unaudited net profit of approximately 16 million Hong Kong dollars for the six months ending September 30, 2024, compared to an unaudited net loss of approximately 8.7 million Hong Kong dollars for the six months ending September 30, 2023. The announcement stated that the expected improvement is mainly due to (i) fair value gains on acceptance bills generated from non-controlling interests during the period; (ii) increased profits from the health product business; and (iii) a decrease in administrative and R&D expenses due to the implementation of cost reduction and efficiency enhancement measures.
Express News | EPS Creative Health Technology -Expected Result Due to Increase in Profits From Healthcare Products Business, Others
Express News | EPS Creative Health Technology Sees Unaudited Net Profit HK$16 Mln for Six Months
EPS HEALTH TECH: POSITIVE PROFIT ALERT
Eps Health Tech (03860.HK): Takashi Kinoe appointed as executive director, chairman, and CEO.
Gelonghui, November 8th | eps health tech (03860.HK) announced that the following appointments and resignations will take effect from November 8, 2024: (1) Tatsuya Shimada has submitted his resignation as executive director, chairman and CEO positions; and (2) Kenichiro Kyuhoku has been appointed as executive director, chairman and CEO.
No Data
No Data